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Background: Drug eluting stents (DES) reduce in-stent restenosis when compared to bare metal stents. However some doubts about their long 
term safety, particularly thrombosis, have been evidenced. With these devices, stent underexpansion and malapposition are considered as potential 
mechanisms favouring thrombosis. These could be prevent by guidance with intravascular ultrasound (IVUS). The aim of this metanalysis is to 
quantify the potential clinical benefit of IVUS guidance.
Methods: We performed a literature search on Pubmed, Embase, Cinhail, Web of Science and the Cochrane Library. Inclusion/exclusion criteria 
were: full-text articles in peer-reviewed journals (2003-2011), we excluded uncontrolled studies. The search included both randomized controlled 
clinical trials (RCT) and observational cohort studies. The following outcomes were metanalyzed: death, acute myocardial infarction (MI), 
revascularization and thrombosis. Pooled fixed or random effect relative risks (RR) and 95% confidence limits (95%CI) were computed.
Results: Overall 217 abstract obtained from the search were evaluated and 26 full texts were retrieved; 13 of them were excluded, being abstract, 
review, metanalysis or for lack of pertinence. Of the 13 articles included in our study 1 was a RCT and 12 were observational studies. A total of 
23143 patients were enrolled, women were 28% . The median age was 64 years. Median follow-up duration was 18 months (25th-75th percentiles 
12-24). IVUS guidance was associated with a significantly lower rate of death (RR 0.58, 95% CI 0.45-0.75, p <0.001), of MI (RR 0.59 95%CI 0.38-
0.92, p=0.021) and of thrombosis (RR 0.66 95%CI 0.48-0.90, p=0.010). Conversely no significant effect was seen for revascularization (RR 1.04, 
95% CI 0.90 to 1.20, p = 0.57).
Conclusions: In this metanalysis, IVUS guidance in DES positioning appears to reduce mortality and MI, possibly by reducing thrombosis rather 
than restenosis rate. Patients at high risk for life threatening thrombosis might be identified as the best candidate for IVUS guidance. More evidence 
from RCT is needed.
